OptimizeRx
OPRX · NASDAQ
$8.93+$0.19 (+2.17%)TodayMarket closed ·
Prev close $8.74
About OPRX
- Employees
- 104
- Headquarters
- Waltham, Massachusetts
- Listed
- May 18, 2005
- Sector
- Health Care
- Industry
- Health Care Technology
- Website
- optimizerx.com
Leadership
| Name | Title | Since |
|---|---|---|
| Lynn Vos | — | — |
| Stephen Silvestro | — | 2019 |
| Edward Stelmakh | — | — |
| Brendan Merrell | — | — |
| Marion Odence-Ford | — | — |
| Doug Besch | — | — |
| Andy D'Silva | — | — |
| Theresa Greco | — | — |
| Catherine Klema | — | — |
| James Lang | — | — |
| Patrick Spangler | — | — |
| Gregory Wasson | — | — |
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Medtronic MDT | Customer | 0.62 |
| Amazon.com AMZN | Supplier | 0.54 |
| Merck MRK.DE | Customer | 0.49 |
| Novo Nordisk B | Customer | -0.28 |
| Molina Healthcare MOH | Customer | -0.36 |
| Novartis NOVN.SW | Customer | -0.42 |
| Pfizer PFE | Customer | -0.47 |
| AstraZeneca AZN.L | Customer | -0.49 |
| Eli Lilly LLY | Customer | -0.51 |
| Becton, Dickinson BDX | Customer | -0.55 |
Similar companies
Companies in the same industry as OptimizeRx
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.